Similar to This
Kraft Group is proposing a $16 billion data center campus in a small ...
Kraft Group is proposing a $16 billion data center campus in a small Massachusetts town
qz.com/kraft-group-sutton-data-center-proposal-111126
Mass. GOP chair won’t seek another term, creating new question for ...
Mass. GOP chair won’t seek another term, creating new question for Republicans: Who will lead them out of the blue wave?
bostonglobe.com/2026/11/09/metro/amy-carnevale-chair-massachusetts-gop-new-leader/
Gaskin: Mass. should capture opportunity in bank mergers
Gaskin: Mass. should capture opportunity in bank mergers: Massachusetts has the resources to lead the next generation of technological innovation ...
bostonherald.com/2026/11/07/gaskin-mass-should-capture-opportunity-in-bank-mergers/
FDA quietly pushes back deadline on electric shock ban
FDA quietly pushes back deadline on electric shock ban: Massachusetts' biggest nursing strike ever, tackling the male loneliness epidemic ...
statnews.com/2026/07/10/health-news-fda-quietly-pushes-back-deadline-on-electric-shock-ban/
Massachusetts DPH pushes back against Trump admin’s ‘harmful’ unproven ...
Massachusetts DPH pushes back against Trump admin’s ‘harmful’ unproven claims about Tylenol use during pregnancy
bostonherald.com/2025/09/26/massachusetts-dph-pushes-back-against-trump-admins-harmful-unproven-claims-about-tylenol-use-during-pregnancy/
Trump-Era Cuts, Harvard Fight Threaten Biotech’s Riskiest Bets
Trump-Era Cuts, Harvard Fight Threaten Biotech’s Riskiest Bets: The Trump administration’s sweeping cuts of federal research funding and its fight with Harvard ...
bloomberg.com/news/articles/2025-05-06/trump-era-cuts-harvard-fight-threaten-biotech-s-riskiest-bets
Bluebird Bio gets gene therapy approval but no business boost
Bluebird Bio gets gene therapy approval but no business boost: The company’s stock fell by more than 40 percent Friday after the approval of Lyfgenia ...
bostonglobe.com/2023/12/12/business/bluebird-sickle-cell-gene-therapy/
Gene-editing therapy by Vertex and CRISPR poised for FDA approval
Gene-editing therapy by Vertex and CRISPR poised for FDA approval: The life-changing drug, developed by Boston-based Vertex and its Swiss partner CRISPR ...
bostonglobe.com/2023/12/02/business/fda-gene-editing-vertex-crispr-sickle-cell/
RSV cases rise in Massachusetts as hopes dim for broad access to new drug ...
RSV cases rise in Massachusetts as hopes dim for broad access to new drug for babies
bostonglobe.com/2023/11/15/metro/rsv-cases-rise/
State told physicians to stop using Magellan Diagnostics lead-testing ...
State told physicians to stop using Magellan Diagnostics lead-testing devices in 2017 and ′21
bostonglobe.com/2023/04/06/metro/state-told-physicians-stop-using-magellan-diagnostics-lead-testing-devices-2017-21/
Over-The-Counter Narcan is a Great First Step, But There's Still Work to ...
Over-The-Counter Narcan is a Great First Step, But There's Still Work to Be Done: Over-the-counter, prescriptionless Narcan could mean that more people have it ...
time.com/6267158/narcan-cost-naloxone-over-the-coutner-next-steps/
Medicare limits coverage of controversial Alzheimer's drug to those in ...
Medicare limits coverage of controversial Alzheimer's drug to those in clinical trials
cnn.com/2022/04/07/politics/alzheimers-drug-aduhelm-medicare-clinical-trial/
Boston puts 812 workers on unpaid leave for failing to get vaccinated
Boston puts 812 workers on unpaid leave for failing to get vaccinated: The Janey administration has put 812 city employees on unpaid leave after they missed ...
bostonglobe.com/2021/10/13/metro/boston-puts-812-workers-unpaid-leave-failing-get-vaccinated/
Federal court approves only school in US using electroshock on students
Federal court approves only school in US using electroshock on students: The FDA banned the use of electric stimulation devices (ESD’s) in March 2020.
thehill.com/changing-america/respect/accessibility/562022-federal-court-approves-only-school-in-us-using